Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $201 Million - $263 Million
1,993,833 New
1,993,833 $258 Million
Q3 2022

Nov 14, 2022

SELL
$75.71 - $119.24 $8.17 Million - $12.9 Million
-107,929 Reduced 5.42%
1,882,998 $208 Million
Q2 2022

Aug 15, 2022

BUY
$62.69 - $88.44 $1.01 Million - $1.42 Million
16,104 Added 0.82%
1,990,927 $149 Million
Q1 2022

May 11, 2022

SELL
$63.15 - $90.42 $2.08 Million - $2.98 Million
-32,912 Reduced 1.64%
1,974,823 $154 Million
Q4 2021

Feb 11, 2022

BUY
$77.28 - $99.42 $3.85 Million - $4.95 Million
49,770 Added 2.54%
2,007,735 $181 Million
Q3 2021

Nov 12, 2021

SELL
$65.97 - $92.48 $1.51 Million - $2.11 Million
-22,824 Reduced 1.15%
1,957,965 $181 Million
Q2 2021

Aug 11, 2021

BUY
$69.38 - $86.75 $13.1 Million - $16.4 Million
189,495 Added 10.58%
1,980,789 $154 Million
Q1 2021

May 13, 2021

BUY
$72.25 - $168.95 $36.6 Million - $85.7 Million
507,151 Added 39.49%
1,791,294 $134 Million
Q4 2020

Feb 09, 2021

BUY
$125.56 - $178.74 $1.61 Million - $2.29 Million
12,811 Added 1.01%
1,284,143 $219 Million
Q3 2020

Nov 12, 2020

SELL
$127.12 - $172.34 $3.16 Million - $4.28 Million
-24,833 Reduced 1.92%
1,271,332 $179 Million
Q2 2020

Aug 12, 2020

BUY
$93.0 - $171.7 $14.9 Million - $27.4 Million
159,776 Added 14.06%
1,296,165 $208 Million
Q1 2020

May 06, 2020

SELL
$82.38 - $131.64 $1.47 Million - $2.34 Million
-17,792 Reduced 1.54%
1,136,389 $111 Million
Q4 2019

Feb 14, 2020

SELL
$76.53 - $135.58 $2.56 Million - $4.53 Million
-33,444 Reduced 2.82%
1,154,181 $149 Million
Q3 2019

Nov 07, 2019

BUY
$72.81 - $156.91 $16.1 Million - $34.8 Million
221,636 Added 22.94%
1,187,625 $89.5 Million
Q2 2019

Aug 12, 2019

BUY
$112.21 - $151.95 $12.3 Million - $16.7 Million
109,743 Added 12.82%
965,989 $147 Million
Q1 2019

May 14, 2019

BUY
$106.67 - $151.68 $30.5 Million - $43.3 Million
285,578 Added 50.04%
856,246 $102 Million
Q4 2018

Feb 11, 2019

BUY
$97.32 - $148.76 $28.4 Million - $43.4 Million
291,823 Added 104.65%
570,668 $62.3 Million
Q3 2018

Nov 09, 2018

BUY
$115.31 - $161.51 $407,851 - $571,260
3,537 Added 1.28%
278,845 $0
Q2 2018

Aug 06, 2018

SELL
$71.74 - $153.69 $3.02 Million - $6.46 Million
-42,033 Reduced 13.25%
275,308 $36.4 Million
Q1 2018

May 15, 2018

SELL
$54.02 - $82.27 $24,038 - $36,610
-445 Reduced 0.14%
317,341 $23.5 Million
Q4 2017

Feb 09, 2018

BUY
$47.64 - $56.75 $15.1 Million - $18 Million
317,786
317,786 $17.7 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $8.73B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.